Clinical Trials
6 trialsNCT03131934 2024-05-17
ITREC
University College, London
Phase EARLY_PHASE1 Unknown
NCT04665063 2020-12-29
A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04666168 2020-12-14
A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04665076 2020-12-11
Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT04610125 2020-10-30
Clinical Trial of CAR-T in the Treatment of Relapsed and Refractory Hematopoietic and Lymphoid Tissue Tumors in Children
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
NCT00899119 2013-12-18
Collecting Stem Cells in Patients With Waldenstrom's Macroglobulinemia
National Cancer Institute (NCI)
Unknown